Searched for
JANSSEN PHARMACEUTICAL
Dr Reddy's launches generic ADD drug in US marketThe company's product is generic version of Janssen Pharmaceuticals' Concerta tablets, Dr Reddy's Laboratories said in a statement.- Biological E signs pact with J&J for Covid-19 vaccine technologyBiological E will produce J&J's vaccine at its vaccine production facilities and sell them both in India and export across various global m...
- Johnson & Johnson arm halts R&D on Hepatitis C drugInstead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by a different virus.
- Lupin launches Ortho-Cyclen tablets in USLupin said, "It has launched its Norgestimate and Ethinyl Estradiol tablets USP, 0.25 mg/0.035 mg having received approval from US FDA earl...
- Piramal Enterprises to buy 5 Janssen drugs for Rs 1,164 croreThe transaction, which is expected to close this week, marks the Ajay Piramal-led company’s sixth deal in the healthcare space in the past ...
- Open for acquisitions especially in OTC space: Nandini Piramal, Piramal EnterprisesThe deal allow us to leverage our distribution and our marketing network in over 50 countries, said Nandini Piramal.
- Piramal to buy select injectable brands from Janssen for up to $175 millionPiramal will pay an upfront cash of $155 million and the rest on meeting certain sales-related milestones, a press release said.
- Glenmark gets USFDA nod for contraceptive tabletsGlenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl estrad...
- Glenmark gets USFDA nod for contraceptive tabletsApproval has been granted for generic version of Ortho Tri-cyclen Lo tablets of Janssen Pharmaceuticals, Inc.
- Dishman gets licence from Johnson & Johnson to produce TB drug raw materialDishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...
- Dishman Pharma hits 52-week high as drug maker gets licence to manufacture TB medicineDishman Pharmaceuticals and Chemicals surged 16.22 per cent to close at 306.95. The stock closed at a fresh 52-week high on Wednesday.
- Janssen India launches diabetes treatment drugTaken orally once a day, Invokana belongs to a new class of medications which work in a completely different way to other classes of type 2...
- Jubilant Biosys expands drug discovery alliance with JanssenJubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...
- Lupin gets USFDA nod for oral contraceptive drugLupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.
- Glenmark settles patent case with Janssen for generic tabletsGlenmark Pharmaceuticals today said it has settled litigation with Janssen Pharmaceuticals Inc over patent actions regarding generic oral c...
- Sun Pharmaceutical awaits USFDA approval for cancer drug LipodoxAfter gaining market access under a USFDA contingency plan, Sun Pharma is awaiting approval for its cancer drug Lipodox.
- Genmab inks $1.1 bn deal with Johnson & JohnsonDanish pharma firm Genmab has said that it had reached a deal worth up to $1.1 bn with US drug giant Johnson & Johnson.
- Sun Pharma gets US FDA nod to sell generic Alzheimer's disease drugSun Pharmaceutical Industries Ltd said it has received an approval from the FDA to sell generic drug galantamine hydrobromide used in treat...
- Sun Pharma announces USFDA approval for Topamax tabletsSun Pharma said US health regulator Food and Drug Administration has approved its Abbreviated New Drug Application (ANDA) to market generic...
- J&J opens new pharma development centreJanssen-Cilag and its parent Johnson and Johnson Pharmaceutical Research and Development (J&JPRD) on Tuesday opened an analytical and pharm...
Load More
